AMAbi Merriel

Abi Merriel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abi Merriel has a total of 281 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

    by K. Anand, T. Bucci, M. Sudell, G. Y. H. Lip, A. Merriel

    Objective: To evaluate the association between fetal growth restriction (FGR) and adverse maternal cardiovascular outcomes within 5 years postpartum. Methods: This was a retrospective study that used a global federated health research network (TriNetX) in which diagnoses are coded using the International Classification of Diseases, tenth revision, Clinical Modification system (ICD‐10‐CM). Nulliparous women aged ≥ 18 years, without prior cardiovascular disease and with a singleton pregnancy delivered between April 2006 and December 2020, were categorized by the presence or absence of FGR (ICD‐10‐CM: O36.5). 1:1 propensity‐score matching (PSM) was applied using two models: Model 1, matching for pre‐existing cardiovascular risk factors; and Model 2, matching for both pre‐existing and other pregnancy‐related cardiovascular risk factors. Cox regression proportional hazard models were used to estimate hazard ratios (HRs) with 95% CI for a maternal composite cardiovascular outcome including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke within 5 years postpartum, and for each of these components individually. Results: After PSM, 84 863 women per group were analyzed in Model 1 and 84 861 per group in Model 2. FGR was associated with an increased risk of the composite cardiovascular outcome (Model 1: HR, 1.33 (95% CI, 1.16–1.52); Model 2: HR, 1.31 (95% CI, 1.15–1.50)), as well as with an increased risk of each of the components of the composite outcome individually: heart failure (Model 1: HR, 1.29 (95% CI, 1.08–1.54); Model 2: HR, 1.30 (95% CI, 1.09–1.56)), acute myocardial infarction (Model 1: HR, 1.55 (95% CI, 1.16–2.08); Model 2: HR, 1.53 (95% CI, 1.15–2.05)) and cerebral infarction/ischemic stroke (Model 1: HR, 1.38 (95% CI, 1.09–1.74); Model 2: HR, 1.33 (95% CI, 1.06–1.68)) within 5 years postpartum. Conclusions: FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke, within 5 years postpartum. These findings suggest that FGR may be a marker of early cardiovascular vulnerability. However, residual confounding, particularly by unmeasured timing or severity of pre‐eclampsia, cannot be excluded. Also, FGR was identified using coding constructs based on electronic health records, which may include overlap with broader ‘suspected poor growth’ phenotypes such as small‐for‐gestational age, hence potentially diluting the observed associations. Earlier risk assessment and preventive strategies may help to reduce the risk of long‐term morbidity and mortality in this population. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

    • 18 November 2026
    • Published by MDPI AG in Preprints.org
      • https://doi.org/10.20944/preprints202611.1772.v1
    Open Access

    Homocysteine, Homocysteine Thiolactone and Protein N-Homocysteinylation in Disorders of Human Pregnancy and Reproduction: Focus on Pre-Eclampsia

    by Douglas B. Kell, Abi Merriel, Louise C. Kenny, Catriona Waitt, J. Bernadette Moore

    Homocysteine (Hcy) is a non-proteinogenic amino acid formed as a normal intermediate of methionine metabolism. Elevated circulating Hcy concentrations are associated with oxidative stress and endothelial dysfunction, and hyperhomocysteinaemia has been associated with cardiovascular diseases. Normal total plasma concentrations of Hcy are considered lie in the range 5-15 mmol/L, though many consider levels above 10 mmol/L to constitute hyperhomocysteinaemia. One potential mechanism linking elevated Hcy to adverse effects is its conversion to a thiolactone (HTL) that can react with the e-amino groups of lysine residues in essentially any protein, resulting in protein N-homocysteinylation. Hcy levels should thus be kept low (but not eliminated as it is required for cysteine production). Plasma Hcy levels are influenced by genetic variation in enzymes involved in one-carbon and transsulphuration metabolism, particularly in low-activity alleles of methylene tetrahydrofolate reductase (MTHFR) and of cystathionine b-synthase (CBS), as well as by the status of B vitamins including folate (B9), and/or B12, and/or pyridoxine (B6), and/or riboflavin (B2). We here review the extensive evidence linking Hcy, HTL and protein N-homocysteinylation with disorders of pregnancy and reproduction, with a particular focus on pre-eclampsia, where oxidative stress and endothelial dysfunction are prominent and established features. Collectively, the evidence supports the importance of ensuring adequate B vitamin status, especially folate, before and during pregnancy, as well as suitable antioxidants. Interventions targeting Hcy metabolism or associated oxidative stress may offer safe and promising approaches to the prevention and treatment of pregnancy complications, warranting further clinical investigation.

  • Open Access

    The development and validation of an antenatal expectations of labour and birth measurement tool: EXPECTBirth Tool

    by Miriam Toolan, Mariusz T. Grzeda, Anna Davies, Emma Harvey, Andrew Demetri, Vicky Bradley, Mary Lynch, Katherine Birchenall, Chloe de Souza, Lucy Willis, et al.

    Background: A mismatch between birth expectations and experience has been linked to lower satisfaction with birth alongside increasing post-traumatic stress symptoms. We aimed to design and validate an instrument to measure birth expectations (EXPECTBirth). Methods: We performed (1) a systematic review of birth expectations to identify instrument content, (2) think aloud interviews to iteratively develop the instrument, (3) an online pilot survey for exploratory analysis and initial item reduction. Using data from an antenatal education intervention development study we performed (4) a Rasch analysis to select best functioning items and (5) responsiveness to change test. We then returned to the data from (3) to undertake (6) test-retest reliability and finally (7) external validity compared to existing gold standard. For element 3,6,7, we carried out a National online survey, for element 4 and 5 we performed a single site implementation development study at large maternity service in Southwest England. Eligible participants were pregnant/postnatal women. Results: An initial 45 item questionnaire was developed based on the systematic review and modified in 14 think aloud interviews. Two hundred and thirty four women completed the pilot online questionnaire (elements 3,6,7) and 143 women completed the antenatal education study and the initial survey (element 4) and 110 of these completed the questionnaire at baseline and follow up and therefore contributed to the responsiveness to change (element 5). The applied statistical procedures led to a 12-item tool for measuring birth expectations that presents satisfactory overall responsiveness to change (Cohen’s average effect size 0.35, showing small-moderate responsiveness), test-retest reliability (Spearman Co-efficient 0.83 p<0.001) and performs well against the existing gold standard Slade-Pais tool, all subscales being at least moderately correlated (rho 0.25 and 0.71). Conclusions: The EXPECTBirth tool can be used to assess expectations of birth quickly and in a neutral manner and investigate whether antenatal interventions alter expectations of birth. Further work is need to understand whether there is an correlation between EXPECTBirth scores and perinatal mental health outcomes.

  • Open Access

    Which Is The Best Method For Induction Of Labour In Low- And Middle-Income Countries?: A Systematic Review And Network Meta-Analysis

    by Victoria Bradley, Alexandra Hunt, Flora Jobson, Rachel Greenwood, Mahmoud Aljubeh, Mohamed Okba, Freddy Fayers, Eve Bunni, Carol Kingdon, Address Malata, et al.

    Background: Globally, induction of labour rates and methods vary according to resource setting. Our aim is to identify the most effective induction of labour method for achieving vaginal birth within 24 hours in low- and middle-income settings without increasing adverse outcomes.Methods: We searched Embase, Medline, Scopus, African Journals Online, CINAHL, Web of Science, Epistemonikos and Cochrane Central to August 2025 with no language restrictions. We included RCTs conducted in LMICs that compared any induction method to placebo or another induction method. We conducted a network meta-analysis using a Bayesian framework and ranking using odds ratios. The relative treatment efficacy ranking of the interventions was determined using the area under the cumulative ranking curve (SUCRA) values. Only trials with low risk of bias were included in the primary analysis.Findings: 207 studies were included (78 low risk, 37 moderate risk, 92 high risk) reporting outcomes for 37, 280 women and 60 induction methods. Low dose oral misoprostol is likely to be the most effective method for achieving vaginal birth within 24 hours (oral misoprostol <50 micrograms vs vaginal misoprostol <50 micrograms OR = 3.36, 95% Credible Interval (CrI) 1.25, 9.95), without increasing the caesarean birth rate (OR 0.98, 95% CrI 0.68, 1.48), NICU admission (OR 0.56, 95% CrI 0.24, 1.18) or Apgar scores <7 at 5 minutes (OR 0.50, 95% CrI 0.10, 2.31). However, compared with vaginal misoprostol<50 micrograms, oral misoprostol <50 micrograms may increase the chance of maternal side-effects including diarrhoea (OR =13.71, 95% CrI 1.44, 381.36) and nausea and vomiting (OR = 2.68, 95% CrI 1.44, 5.26).Interpretation: Low dose oral misoprostol appears to be most efficacious for achieving vaginal birth within 24 hours without increasing the incidence of adverse outcomes. For each woman selecting the best induction method involves a tradeoff between effectiveness, side-effects risks and benefits.

  • Open Access

    The Gini coefficient as a surrogate for the regulability or homeostasis of metabolite concentrations: focus on ergothioneine

    by Douglas B. Kell, Warwick B. Dunn, Catherine L. Winder, Keerthana Anand, Benjamin Greenfield, Louise C. Kenny, Abi Merriel, J. Bernadette Moore, Catriona Waitt

    The Gini coefficient is a simple non-parametric statistic that reflects the degree of variation of a property between individuals or samples, taking a value between zero and one. We here develop the idea that if the metabolism of a metabolite is tightly regulated it should have a low Gini coefficient whereas if for instance it is exogenous and present only in a subset of samples (e.g. from individuals that have ingested the substance and/or metabolised it to various degrees) the Gini coefficient will be much greater. Analysis of published datasets shows this to be true, allowing one to suggest that the Gini coefficient might assist in assessing both regulability and the origin of a particular metabolite. Plasma amino acid levels are especially tightly regulated (some have a Gini coefficient less than 0.1, a value lower than that for any transcript), while exogenous drugs and their metabolites have the highest Gini coefficients (some over 0.8). Vitamins are essential and exogenous (but regulated) and have intermediate values (ca. 0.2–0.4). Ergothioneine is a valuable nutraceutical that is not synthesised by humans and it is also of some interest to assess the variation in its distribution. A number of studies find it normally to have a Gini coefficient in the range 0.3–0.4, and with lower levels of the Gini coefficient (as in a pilot study summarised here) suggesting a relatively weak exogenous exposure. Overall, we consider that the Gini coefficient provides a convenient means of describing the extent to which a metabolite concentration varies over a metabolomic dataset, and hence the extent to which it may be regulated.

  • Open Access

    More than a lack of resources: a mixed-methods assessment of the barriers and facilitators to infection prevention practices in three low-resource maternity units in Malawi

    by Jennifer M Riches, Chimwemwe Kachiwaya, Marthe Onrust, Linda Nyondo-Mipando, Catriona Waitt, Abi Merriel, David Lissauer

    Background: Maternal sepsis is a leading cause of maternal mortality and morbidity. Caesarean section is a risk factor for infection, particularly in low-resource settings. This study aimed to identify barriers and facilitators to recommended infection prevention (IP) practices prior to implementation of a complex intervention to improve IP during caesarean section in a low-resource setting. Methods: This was a mixed methods study conducted in three semi-rural maternity hospitals in Malawi between June and December 2022. Participants were healthcare workers (HCWs) and women undergoing caesarean section. Data collection included case note review, weekly surveys and ethnographic participant observation to assess resource availability for IP and adherence to recommended IP practice. Preliminary data were integrated and used to inform in-depth interviews with HCWs to further explain findings. Inductively coded themes from interviews were mapped to the Communication-Opportunity-Motivation-Behaviour (COM-B)/Theoretical Domains Framework (TDF) model. Results: We found a lack of resources and suboptimal infrastructure for IP across the facilities, with many basic items available only intermittently. Observation revealed significant gaps in recommended IP practices, including hand hygiene, aseptic technique during vaginal examination, surgical scrubbing and sterile practice in the operating theatre. Scarcity of resources and infrastructure functioned as both direct and indirect barriers to IP due to their impact on staff motivation (reflective and automatic). Having ‘passion’ for patients, regular senior supervision and ‘reminders’ acted as facilitators to recommended IP practice. Conclusion: Our study demonstrates that adherence to recommended IP practice is determined by more than the availability of resources; the indirect impact of scarcity on staff motivation also played an important role. The study identified further barriers and facilitators to general IP practices, the understanding of which was subsequently used in the selection and development of a complex behaviour change intervention to improve IP practices in the same facilities.


  • Open Access

    Vaginal Misoprostol Compared to Vaginal Dinoprostone for Induction of Labour: A Systematic Review and Meta‐Analysis

    by Georgina Andersson, Benjamin Greenfield, Alexandra Hunt, Amr Malawany, Ben Luke Choo, William Dixon, David Lissauer, Andrew D. Weeks, Andrew Sharp, Gemma Clayton, et al.

    Introduction: Induction of labour is a common intervention. The prostaglandin dinoprostone is often used, but there is increasing evidence that misoprostol may be more effective without compromising safety. This review compares the efficacy and safety of vaginal misoprostol and vaginal dinoprostone. Methods: Electronic databases were searched for randomised controlled trials comparing singleton, term inductions with vaginal dinoprostone or vaginal misoprostol. The primary outcome was vaginal births within 24 h. Secondary outcomes included induction to birth interval, mode of birth, oxytocin augmentation, uterine hyperstimulation, fetal distress and adverse maternal and neonatal outcomes. A sub‐group analysis by misoprostol dosage (25 and ≥ 50 μg) was planned. A random effects meta‐analysis was performed and risk of bias assessed using Cochrane Risk of Bias 2 tool. Results: 44 papers reported 7040 participants induced with vaginal misoprostol and 6604 with vaginal dinoprostone. Participants given vaginal misoprostol were 48% (OR 1.48 95% CI 1.20, 1.84) more likely to achieve vaginal birth within 24 h, although heterogeneity was high. The rates of caesarean section, and adverse maternal or neonatal outcomes were comparable. In the vaginal misoprostol group, fewer patients required oxytocin (OR 0.51 95% CI 0.40, 0.65) and time to birth was reduced (−230 min (95% CI −286 to −175, I 2 57.6%)). These findings were consistent in the subgroup analysis, although uterine hyperstimulation with fetal heart rate changes was reduced in the 25‐μg group. Conclusion: Vaginal misoprostol is more effective for achieving vaginal birth in 24 h, reducing time to birth and oxytocin use when compared to vaginal dinoprostone. It does not seem to increase caesarean birth and has a similar side‐effect profile. At lower doses (25‐μg), it is likely to be similarly effective with a lower incidence of uterine hyperstimulation. This information can be used to support discussions around choice of induction agent.

  • Open Access

    Clinicians’ decision-making about broad-spectrum antibiotic prescribing for suspected maternal sepsis during childbirth in the UK: a qualitative study

    by Carol Kingdon, Benjamin Greenfield, Caroline Cunningham, David Freeman, Damien Ming, David Lissauer, Alison Holmes, Abi Merriel

    Objective: Sepsis management and antimicrobial resistance (AMR) are linked priorities. Early identification and treatment of sepsis with broad-spectrum antibiotics are key to reducing morbidity and mortality. We aimed to investigate clinicians’ decision-making about broad-spectrum antibiotics for suspected maternal sepsis in women admitted to hospital for childbirth, to identify if, how and why overtreatment may occur. Design: Qualitative study. Semistructured interviews were conducted online, transcribed verbatim, coded in MAXQDA and analysed using the thematic Framework Approach. Setting: National Health Service (NHS) in England, Scotland and Wales, March–June 2024. Participants: 24 clinicians, purposively sampled for representation from relevant professions with roles in decision-making (n=15 obstetricians; n=4 anaesthetists; n=3 midwives; n=2 microbiologists). Results: Participants report increasing numbers of women in labour are being prescribed broad-spectrum antibiotics for suspected maternal sepsis per guidelines. Fear of missing sepsis, absence of evidence about sepsis during labour and beliefs about antibiotic use informed clinicians’ views, impacting workloads and women’s experiences. 9/24 participants said overtreatment is a problem; 21/24 believed overtreatment occurs. Clinicians’ beliefs, views and experiences are reported in three themes that provide a framework to explain how clinicians navigate guidelines including; why overtreatment can occur (Theme 1: The sepsis guideline is more than a guideline); how decisions to prescribe broad-spectrum antibiotics during labour are made (Theme 2: Trying to balance the whole picture) and where clinicians’ think the bigger picture problems lie (Theme 3: If we continue down this path where might we be). The framework encapsulates clinicians’ tacit knowledge governing decision-making and guideline use. Conclusions: Clinicians link priorities for sepsis management and AMR, but antimicrobial stewardship comes second to concerns about missing sepsis in high-stakes maternity care. Overtreatment may be inevitable until better evidence to support decision-making for suspected maternal sepsis and point-of-care diagnostic tests for women in labour exist and are embedded in clinical guidelines and clinicians’ mindlines.


  • Management and long-term surveillance of hypertensive disorders of pregnancy

    by Babu Karavadra, Keerthana Anand, Abi Merriel, Eduard Shantsila

  • Open Access

    What should be discussed when considering an induction of labour? A UK-wide, multi-centre Delphi study to develop a core information set for induction of labour

    by Eve Bunni, Carol Kingdon, Vicky Bradley, Alexandra Hunt, Amy Mahdi, Thomas Axcell, Ria Jagadish, Sophie Fox, Millie O'DAir, Charlotte Simms, et al.

    Objective To develop a core information set for induction of labour. Rates of induction of labour for childbirth are rising in many high-income countries. In England, a third of women have their labours induced. National guidelines recommend women receive information to make informed decisions about induction. Design Two-stage consensus study using modified Delphi. Setting UK. Participants Pregnant people, parents and professionals. Outcomes Stage 1: A long list of information points was identified through a systematic review of reviews, reviewing patient leaflets, qualitative interviews and a stakeholder survey, with ongoing patient, public and professional involvement. Stage 2: Think-aloud interviews were undertaken to refine the Delphi survey before a two-round modified Delphi process where participants voted on the importance of the information items. Pre-specified criteria were used to select items taken forward to a consensus meeting. Results 199 information points were identified through systematic review (110), patient information leaflets (162), qualitative interviews (58) and a survey (93). 46 unique information items entered the first Delphi round after four think-aloud interviews, 2 items were added following round 2. 368 people (310 parents/58 professionals) participated in round 1 and 177 people (154 parents/23 professionals) in round 2. 44 items met inclusion criteria; one item excluded, and three items were carried forward for consensus meeting discussion where 12 overarching information points were agreed on. Conclusions This study has established a consensus-based core information set for induction of labour from a sample of the birthing population and staff providing their care. The resultant set has been populated with evidence in line with national guidelines. It can be used by women and clinicians as a standardised starting point from which to personalise discussions about birth. Trial registration number COMET Initiative registration 2600: Developing a core information set for induction of labour.